Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    TopAbstracts in Diabetes 01/06/2009 - (DGNews)
    TopAbstracts in Diabetes 12/30/2008 - (DGNews)
    TopAbstracts in Diabetes 12/23/2008 - (DGNews)
    Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan - (DGNews)
    Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes - (N Engl J Med)

    News archive

     Recent webcasts/CME - Diabetes
      Achieving Glycemic Control in Type II Diabetes: Where Are We in 2008?
      Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play
      Current Concepts in Diagnosing and Treating MRSA in the Diabetic Foot
      Diabetes: Treatment of Type 2 Diabetes and the Role of Insulin
      Aggressive Management of Type 2 Diabetes to Prevent Macrovascular Complications

      Webcasts/CME archive

       Recent cases - Diabetes
        Atypical Ketosis-Prone Diabetes
        Bilateral Dystonia in Type 1 Diabetes: A Case Report
        Lisfranc Fracture-Dislocation Precipitating Acute Charcot Arthopathy in a Neuropathic Diabetic Foot: A Case Report
        Emphysematous Pyelonephritis in Type II Diabetes: A Case Report of an Undiagnosed Ureteric Colic
        Vitamin D and Diabetes: Improvement of Glycemic Control with Vitamin D3 Repletion

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        More Aggressive Diabetes Treatment Needed: Presented at AAFP

        By Crystal Phend

        SAN FRANCISCO, CA -- October 11, 2005 -- Physicians need to treat diabetes more aggressively and use all available tools to prevent cardiovascular disease, according to a diabetes management presentation at the annual meeting of the American Academy of Family Physicians (AAFP).

        "Treat to target, not to failure," was the theme of the presentation here on September 28th.

        Primary care physicians treat about 90% of all patients with diabetes in the United States, but receive relatively little training in medical school on the subject, said Jeff Unger, MD, Director, Chino Medical Group Diabetes and Headache Intervention Center, Chino, California, United States.

        Guidelines from the American Diabetes Association and other organizations suggest that the target hemoglobin (Hb) A1c level, which reflects blood sugar control, should be 7%. The average in the United States is 9% and about 20% of individuals with diabetes have HbA1c levels above 11%, according unpublished data he presented from the Texas Department of Health.

        The best prevention is to manage diet and lifestyle aggressively, but physicians should be wary of trying to manage the disease that way, he said. "Patients will come in and say, 'Don't worry doc', I'll control it with diet and exercise,'" Dr. Unger said. "That does not work."

        Both type 1 and 2 diabetes are progressive diseases, so most patients over time will need insulin therapy, Dr. Unger said.

        He recommended that patients be started on insulin therapy when they are symptomatic, unable to achieve acceptable HbA1c levels within 2 to 4 months of starting triple combination oral therapy, under special conditions like infections, hospitalization, or pregnancy, or if they have triglyceride levels above 700 mg/dL, especially if patients have coronary artery disease.

        "Early intervention with insulin can reduce long-term complications," he said.

        To rapidly get HbA1c levels down to target levels, he recommends a forced titration of split dose insulin, with patients taking injections at breakfast that are adjusted by the previous pre-dinner blood glucose level and vice versa.

        The patient should call their physician's office to report their blood glucose level so the nurse can instruct them on how to adjust the insulin dose. Target fasting blood glucose levels should be 80 to 100 mg/dL and dinner glucose levels should be <140 mg/dL.

        This regimen typically gets levels under control within 12 weeks, Dr. Unger said. "It's easy, it's safe, it's effective," he said, adding that "82% of your patients will go down to AIc 7%."

        Inhaled insulin, which is expected to be available in the next 3 to 4 months in the United States, may be a good idea as a bridge therapy to injections, Dr. Unger said. Also, he suggested that statins should be used to control cardiovascular risk for diabetics over age 30.

        "Aggressive control of hyperglycemia and diabetes risk factors reduce micro- and macrovascular complications and decrease endothelial inflammation, Dr. Unger said. "Your patient will live longer with less morbidity!"


        [Presentation title: Intensive Diabetes Management: A Physiologic Approach. Session 536]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send